Meanwhile, the combination of ZC-22 and cisplatin remarkably inhibited cell proliferation and Rb phosphorylation and aggravated DNA damage to a higher level than ZC-22 or cisplatin alone in ovarian cancer cells (Figure 7D,E and Supplementary Figure S5A,B). This evidence concerns the gene RB1 and ovarian carcinoma.